vimarsana.com

Latest Breaking News On - Buda health clinic - Page 1 : vimarsana.com

12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research

Uppsala, January 24, 2024. OssDsign AB (publ.) today announces that the previously communicated outstanding 12-month results from the clinical study TOP FUSION have been published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research. The results show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with the novel nanosynthetic bone graft OssDsign Catalyst.

Karolinska Development s portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

Karolinska Development s portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

OssDsign reports exceptional data from the clinical study TOP FUSION

OssDsign reports exceptional data from the clinical study TOP FUSION
realtid.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realtid.se Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.